作者: T.S. Aukema , E.J.Th. Rutgers , W.V. Vogel , H.J. Teertstra , H.S. Oldenburg
DOI: 10.1016/J.EJSO.2009.11.009
关键词: Predictive value of tests 、 Chi-squared distribution 、 Positron emission tomography 、 In patient 、 Nuclear medicine 、 Medicine 、 Breast cancer 、 Tomography 、 Whole body imaging 、 Breast cancer recurrence 、 Radiology
摘要: Abstract Purpose The aim of this study was to evaluate the impact 18 F-fluorodeoxyglucose positron-emission tomography/computed tomography (FDG PET/CT) on clinical management in patients with locoregional breast cancer recurrence amenable for treatment and compare PET/CT results conventional imaging data. Patients methods From January 2006 August 2008, all underwent whole-body PET/CT. findings were compared techniques final pathology. evaluated based decisions obtained from patient files. Results 56 included. In 32 (57%) revealed additional tumour localisations. Distant metastases detected 11 23 images ( p Conclusions PET/CT, addition techniques, plays an important role staging since its result changed almost half patients. could potentially replace a recurrence.